<SEC-DOCUMENT>0001178913-22-004096.txt : 20221117
<SEC-HEADER>0001178913-22-004096.hdr.sgml : 20221117
<ACCEPTANCE-DATETIME>20221117164022
ACCESSION NUMBER:		0001178913-22-004096
CONFORMED SUBMISSION TYPE:	SC 13D/A
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20221117
DATE AS OF CHANGE:		20221117
GROUP MEMBERS:		KOBI GEORGE

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Chemomab Therapeutics Ltd.
		CENTRAL INDEX KEY:			0001534248
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				813676773
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13D/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-86953
		FILM NUMBER:		221398988

	BUSINESS ADDRESS:	
		STREET 1:		KIRYAT ATIDIM, BUILDING 7
		CITY:			TEL AVIV
		STATE:			L3
		ZIP:			6158002
		BUSINESS PHONE:		972-77-331-0156

	MAIL ADDRESS:	
		STREET 1:		KIRYAT ATIDIM, BUILDING 7
		CITY:			TEL AVIV
		STATE:			L3
		ZIP:			6158002

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Anchiano Therapeutics Ltd.
		DATE OF NAME CHANGE:	20180906

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BioCancell Ltd.
		DATE OF NAME CHANGE:	20111104

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Mor George Adi
		CENTRAL INDEX KEY:			0001851069

	FILING VALUES:
		FORM TYPE:		SC 13D/A

	MAIL ADDRESS:	
		STREET 1:		15 KAFRISIN ST.
		CITY:			TEL AVIV
		STATE:			L3
		ZIP:			6901658
</SEC-HEADER>
<DOCUMENT>
<TYPE>SC 13D/A
<SEQUENCE>1
<FILENAME>zk2228783.htm
<DESCRIPTION>SC 13D/A
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: ZKG
         Document created using Broadridge PROfile 22.10.1.5080
         Copyright 1995 - 2022 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <div class="BRPFPageHeader">
      <div style="line-height: 1.25;">
        <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-size: 14pt; font-weight: bold; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">SECURITIES AND EXCHANGE COMMISSION</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">WASHINGTON, D.C. 20549</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-size: 14pt; font-weight: bold; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">SCHEDULE 13D</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">Under the Securities Exchange Act of 1934</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO 240.13d-2(a) AND AMENDMENTS </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">THERETO FILED PURSUANT TO 240.13d-2(a)</div>
    <div style="text-align: center; line-height: 1.25;"><font style="font-weight: bold;">(Amendment No. 1)*</font>&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z61a4c73634f44ce8add644343e8bd492">

        <tr>
          <td style="width: 100%; vertical-align: middle;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 100%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-size: 16pt; font-weight: bold; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">Chemomab Therapeutics Ltd.</div>
            <div style="text-align: center; line-height: 1.25;"><font style="font-weight: bold;">(</font>Name of Issuer)</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="za7585b8263dc458cbd09eff632d4f60d">

        <tr>
          <td style="width: 100%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">American Depositary Shares, each of which represents twenty Ordinary Shares, no par value</div>
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">Ordinary Shares, no par value</div>
          </td>
        </tr>

    </table>
    <div style="text-align: center; line-height: 1.25;">(Title of Class of Securities)</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" id="z473a77eb238947c082cb45e75ee1ee72">

        <tr>
          <td style="width: 100%; vertical-align: middle;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 100%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">16385C104</div>
          </td>
        </tr>

    </table>
    <div style="text-align: center; line-height: 1.25;">(CUSIP Number)</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">Adi Mor<br>
      Kiryat Atidim, Building 7</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">Tel Aviv 6158002, Israel</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">+972-77-331-0156</div>
    <div style="text-align: center; line-height: 1.25;">_______________________________________________________________________________<br>
      (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">
      <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-weight: bold;">November 16, 2022</div>
    </div>
    <div style="text-align: center; line-height: 1.25;">____________________________________________________________________________________</div>
    <div style="text-align: center; line-height: 1.25;">(Date of Event Which Requires Filing of this Statement)</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of
      sections 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. &#9744;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;">*The information required on the remainder of this cover page shall not be deemed to be &#8220;filed&#8221; for the purpose of Section 18 of the Securities Exchange Act of 1934, as amended
      (the &#8220;<u>Exchange Act</u>&#8221;) or otherwise subject to the liabilities of that section of the Exchange Act but shall be subject to all other provisions of the Exchange Act (however, <font style="font-style: italic;">see </font>the Notes).</div>
    <div style="line-height: 1.25">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div class="BRPFPageHeader">
      <div style="line-height: 1.25;">
        <div style="line-height: 1.25;">
          <table cellspacing="0" cellpadding="0" border="0" id="z29f0769244ac4cbfb7c6de7a5a90669e" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;">

              <tr>
                <td style="width: 50.00%;">
                  <div>CUSIP No.&#160;<u>16385C104</u>&#160; &#160; &#160; &#160; </div>
                </td>
                <td style="width: 50.00%;">
                  <div style="text-align: center;"><font style="font-family: 'Times New Roman',Times,serif;">Page 2 of 6 Pages</font></div>
                </td>
              </tr>

          </table>
        </div>
        <div style="line-height: 1.25;"> &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160;&#160; <br>
        </div>
      </div>
      <div style="line-height: 1.25;">
        <div>
          <div style="DISPLAY: block; TEXT-INDENT: 0pt">
            <div align="left">
              <table width="100%" cellspacing="0" cellpadding="5" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">

                  <tr valign="top">
                    <td width="7%" style="border-width: 2px 1px 2px 2px; border-style: solid none solid solid; border-color: black; text-align: left; vertical-align: top;"><font size="2" style="font-family: times new roman,times,serif;">1</font></td>
                    <td width="7%" colspan="3" style="BORDER-RIGHT: black 2px solid; BORDER-TOP: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">
                      <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">NAMES OF REPORTING PERSONS</div>
                      <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;"> <br>
                      </div>
                      <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">
                        <div style="line-height: 1.25;">Adi Mor</div>
                      </div>
                    </td>
                  </tr>
                  <tr valign="top">
                    <td width="7%" style="border-right: 1px none black; border-left: 2px solid black; border-bottom: 2px solid black; text-align: left; vertical-align: top;"><font size="2" style="font-family: times new roman,times,serif;">2</font></td>
                    <td width="7%" colspan="3" style="BORDER-RIGHT: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">
                      <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)&#160; <br>
                      </div>
                      <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;"> (a) &#9744;</div>
                      <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">(b) &#9744;</div>
                    </td>
                  </tr>
                  <tr valign="top">
                    <td width="7%" style="border-right: 1px none black; border-left: 2px solid black; border-bottom: 2px solid black; text-align: left; vertical-align: top;"><font size="2" style="font-family: times new roman,times,serif;">3</font></td>
                    <td width="7%" bgcolor="#cceeff" colspan="3" style="BORDER-RIGHT: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font size="2" style="FONT-FAMILY: times new roman, times, serif">SEC Use
                        Only <br>
                        &#160; </font></td>
                  </tr>
                  <tr valign="top">
                    <td width="7%" style="border-right: 1px none black; border-left: 2px solid black; border-bottom: 2px solid black; text-align: left; vertical-align: top;"><font size="2" style="font-family: times new roman,times,serif;">4</font></td>
                    <td width="7%" colspan="3" style="BORDER-RIGHT: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">
                      <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">SOURCE OF FUNDS (See Instructions)</div>
                      <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;"> <br>
                      </div>
                      <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">
                        <div style="line-height: 1.25;">PF</div>
                      </div>
                    </td>
                  </tr>
                  <tr valign="top">
                    <td width="7%" style="border-right: 1px none black; border-left: 2px solid black; border-bottom: 2px solid black; text-align: left; vertical-align: top;"><font size="2" style="font-family: times new roman,times,serif;">5</font></td>
                    <td width="7%" colspan="3" style="BORDER-RIGHT: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">
                      <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e)&#160; &#160; &#160; &#160; &#160; &#160;</div>
                      <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;"> <br>
                      </div>
                      <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;"> &#9744;</div>
                    </td>
                  </tr>
                  <tr valign="top">
                    <td width="7%" style="border-right: 1px none black; border-left: 2px solid black; border-bottom: 2px solid black; text-align: left; vertical-align: top;"><font size="2" style="font-family: times new roman,times,serif;">6</font></td>
                    <td width="7%" colspan="3" style="BORDER-RIGHT: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">
                      <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">CITIZENSHIP OR PLACE OF ORGANIZATION</div>
                      <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;"> <br>
                      </div>
                      <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">
                        <div style="line-height: 1.25;">Israel</div>
                      </div>
                    </td>
                  </tr>
                  <tr valign="top">
                    <td width="7%" valign="middle" colspan="2" rowspan="4" style="BORDER-LEFT: black 2px solid; BORDER-BOTTOM: black 2px solid">&#160;
                      <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">NUMBER OF</div>
                      <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">SHARES</div>
                      <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">BENEFICIALLY</div>
                      <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">OWNED BY</div>
                      <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">EACH</div>
                      <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">REPORTING</div>
                      <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">PERSON WITH</div>
                    </td>
                    <td width="7%" style="border-left: 2px solid black; border-bottom: 2px solid black; text-align: left; vertical-align: top;"><font size="2" style="font-family: times new roman,times,serif;">7</font></td>
                    <td width="79%" style="BORDER-RIGHT: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">
                      <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">SOLE VOTING POWER</div>
                      <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;"> <br>
                      </div>
                      <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">0<br>
                      </div>
                    </td>
                  </tr>
                  <tr valign="top">
                    <td width="7%" style="border-left: 2px solid black; border-bottom: 2px solid black; text-align: left; vertical-align: top;"><font size="2" style="font-family: times new roman,times,serif;">8</font></td>
                    <td width="7%" style="BORDER-RIGHT: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">
                      <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">SHARED VOTING POWER</div>
                      <div style="line-height: 1.25;"><font style="line-height: 1.25;">&#160;</font></div>
                      <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">
                        <div style="line-height: 1.25;">747,445 (1)</div>
                      </div>
                    </td>
                  </tr>
                  <tr valign="top">
                    <td width="7%" style="border-left: 2px solid black; border-bottom: 2px solid black; text-align: left; vertical-align: top;"><font size="2" style="font-family: times new roman,times,serif;">9</font></td>
                    <td width="7%" style="BORDER-RIGHT: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">
                      <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">SOLE DISPOSITIVE POWER</div>
                      <div style="line-height: 1.25;"><font style="line-height: 1.25;">&#160;</font></div>
                      <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">0</div>
                    </td>
                  </tr>
                  <tr valign="top">
                    <td width="7%" style="border-left: 2px solid black; border-bottom: 2px solid black; text-align: left; vertical-align: top;"><font size="2" style="font-family: times new roman,times,serif;">10</font></td>
                    <td width="7%" style="BORDER-RIGHT: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">
                      <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">SHARED DISPOSITIVE POWER</div>
                      <div style="line-height: 1.25;"><font style="line-height: 1.25;">&#160;</font></div>
                      <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">
                        <div style="line-height: 1.25;">747,445 (1)</div>
                      </div>
                    </td>
                  </tr>
                  <tr valign="top">
                    <td width="7%" style="border-right: 1px none black; border-left: 2px solid black; border-bottom: 2px solid black; text-align: left; vertical-align: top;"><font size="2" style="font-family: times new roman,times,serif;">11</font></td>
                    <td width="7%" colspan="3" style="BORDER-RIGHT: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-BOTTOM: black 2px solid">
                      <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON</div>
                      <div style="line-height: 1.25;"><font style="line-height: 1.25;">&#160;</font></div>
                      <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">
                        <div style="line-height: 1.25;">747,445 (1)</div>
                      </div>
                    </td>
                  </tr>
                  <tr valign="top">
                    <td width="7%" style="border-right: 1px none black; border-left: 2px solid black; border-bottom: 2px solid black; text-align: left; vertical-align: top;"><font size="2" style="font-family: times new roman,times,serif;">12</font></td>
                    <td width="7%" colspan="3" style="BORDER-RIGHT: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-BOTTOM: black 2px solid">
                      <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)</div>
                      <div style="text-align: left; line-height: 1.25;">&#160;<br>
                      </div>
                      <div style="text-align: left; line-height: 1.25;">&#9744; </div>
                    </td>
                  </tr>
                  <tr valign="top">
                    <td width="7%" style="border-right: 1px none black; border-left: 2px solid black; border-bottom: 2px solid black; text-align: left; vertical-align: top;"><font size="2" style="font-family: times new roman,times,serif;">13</font></td>
                    <td width="7%" colspan="3" style="BORDER-RIGHT: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-BOTTOM: black 2px solid">
                      <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)</div>
                      <div style="line-height: 1.25;"><font style="line-height: 1.25;">&#160;</font></div>
                      <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">
                        <div style="line-height: 1.25;">6.4% (2)</div>
                      </div>
                    </td>
                  </tr>
                  <tr valign="top">
                    <td width="7%" style="border-right: 1px none black; border-left: 2px solid black; border-bottom: 2px solid black; text-align: left; vertical-align: top;"><font size="2" style="font-family: times new roman,times,serif;">14</font></td>
                    <td width="7%" colspan="3" style="BORDER-RIGHT: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-BOTTOM: black 2px solid">
                      <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">TYPE OF REPORTING PERSON (See Instructions)</div>
                      <div style="line-height: 1.25;"><font style="line-height: 1.25;">&#160;</font></div>
                      <div style="line-height: 1.25;">IN<font style="line-height: 1.25;"> </font></div>
                    </td>
                  </tr>

              </table>
            </div>
          </div>
          <div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>
        </div>
      </div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zbbe8de6e5fe84956a6c55906d92896e9">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">(1)</td>
          <td style="width: auto; vertical-align: top;">
            <div>
              <div style="line-height: 1.25;">Consists of (i) 324,775 ADSs owned directly by the Reporting Person, (ii) 257,247 ADSs owned by Prof. Kobi George (the Reporting Person&#8217;s spouse), (iii) 131,698 ADSs issuable upon the exercise of options held
                by the Reporting Person, and (iv) 33,725 ADSs issuable to Prof. Kobi George upon the exercise of options held by him.</div>
            </div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zf7bc87c5884e452093b47575fe28919f">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top;">(2)</td>
          <td style="width: auto; vertical-align: top;">
            <div>
              <div style="line-height: 1.25;">The percentage presented is based on 11,525,605 ADSs outstanding as of November 8, 2022, as reported by the Issuer in its Form 10-Q, as filed with the Securities and Exchange Commission on November 10, 2022.</div>
            </div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25"> <br>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;">
      <table cellspacing="0" cellpadding="0" border="0" id="z29f0769244ac4cbfb7c6de7a5a90669e" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; color: #000000; width: 100%;">

          <tr>
            <td style="width: 50.00%;">
              <div>CUSIP No.&#160;<u>16385C104</u>&#160; &#160; &#160; &#160; </div>
            </td>
            <td style="width: 50.00%;">
              <div style="text-align: center;"><font style="font-family: 'Times New Roman',Times,serif;">Page 3 of 6 Pages</font></div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"> &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160;&#160; <br>
      </div>
      <div style="line-height: 1.25;">
        <div>
          <div style="DISPLAY: block; TEXT-INDENT: 0pt">
            <div align="left">
              <table width="100%" cellspacing="0" cellpadding="5" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">

                  <tr valign="top">
                    <td width="7%" style="border-width: 2px 1px 2px 2px; border-style: solid none solid solid; border-color: black; text-align: left; vertical-align: top;"><font size="2" style="font-family: times new roman,times,serif;">1</font></td>
                    <td width="7%" colspan="3" style="BORDER-RIGHT: black 2px solid; BORDER-TOP: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">
                      <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">NAMES OF REPORTING PERSONS</div>
                      <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;"> <br>
                        <div style="line-height: 1.25;">Kobi George</div>
                      </div>
                      <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;"> </div>
                    </td>
                  </tr>
                  <tr valign="top">
                    <td width="7%" style="border-right: 1px none black; border-left: 2px solid black; border-bottom: 2px solid black; text-align: left; vertical-align: top;"><font size="2" style="font-family: times new roman,times,serif;">2</font></td>
                    <td width="7%" colspan="3" style="BORDER-RIGHT: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">
                      <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)&#160; <br>
                      </div>
                      <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;"> (a) &#9744;</div>
                      <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">(b) &#9744;</div>
                    </td>
                  </tr>
                  <tr valign="top">
                    <td width="7%" style="border-right: 1px none black; border-left: 2px solid black; border-bottom: 2px solid black; text-align: left; vertical-align: top;"><font size="2" style="font-family: times new roman,times,serif;">3</font></td>
                    <td width="7%" bgcolor="#cceeff" colspan="3" style="BORDER-RIGHT: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font size="2" style="FONT-FAMILY: times new roman, times, serif">SEC Use
                        Only <br>
                        &#160; </font></td>
                  </tr>
                  <tr valign="top">
                    <td width="7%" style="border-right: 1px none black; border-left: 2px solid black; border-bottom: 2px solid black; text-align: left; vertical-align: top;"><font size="2" style="font-family: times new roman,times,serif;">4</font></td>
                    <td width="7%" colspan="3" style="BORDER-RIGHT: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">
                      <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">SOURCE OF FUNDS (See Instructions)</div>
                      <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;"> <br>
                      </div>
                      <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">
                        <div style="line-height: 1.25;">PF</div>
                      </div>
                    </td>
                  </tr>
                  <tr valign="top">
                    <td width="7%" style="border-right: 1px none black; border-left: 2px solid black; border-bottom: 2px solid black; text-align: left; vertical-align: top;"><font size="2" style="font-family: times new roman,times,serif;">5</font></td>
                    <td width="7%" colspan="3" style="BORDER-RIGHT: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">
                      <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e)&#160; &#160; &#160; &#160; &#160; &#160;</div>
                      <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;"> <br>
                      </div>
                      <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;"> &#9744;</div>
                    </td>
                  </tr>
                  <tr valign="top">
                    <td width="7%" style="border-right: 1px none black; border-left: 2px solid black; border-bottom: 2px solid black; text-align: left; vertical-align: top;"><font size="2" style="font-family: times new roman,times,serif;">6</font></td>
                    <td width="7%" colspan="3" style="BORDER-RIGHT: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">
                      <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">CITIZENSHIP OR PLACE OF ORGANIZATION</div>
                      <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;"> <br>
                      </div>
                      <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">
                        <div style="line-height: 1.25;">Israel</div>
                      </div>
                    </td>
                  </tr>
                  <tr valign="top">
                    <td width="7%" valign="middle" colspan="2" rowspan="4" style="BORDER-LEFT: black 2px solid; BORDER-BOTTOM: black 2px solid">&#160;
                      <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">NUMBER OF</div>
                      <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">SHARES</div>
                      <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">BENEFICIALLY</div>
                      <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">OWNED BY</div>
                      <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">EACH</div>
                      <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">REPORTING</div>
                      <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">PERSON WITH</div>
                    </td>
                    <td width="7%" style="border-left: 2px solid black; border-bottom: 2px solid black; text-align: left; vertical-align: top;"><font size="2" style="font-family: times new roman,times,serif;">7</font></td>
                    <td width="79%" style="BORDER-RIGHT: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">
                      <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">SOLE VOTING POWER</div>
                      <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;"> <br>
                      </div>
                      <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">0<br>
                      </div>
                    </td>
                  </tr>
                  <tr valign="top">
                    <td width="7%" style="border-left: 2px solid black; border-bottom: 2px solid black; text-align: left; vertical-align: top;"><font size="2" style="font-family: times new roman,times,serif;">8</font></td>
                    <td width="7%" style="BORDER-RIGHT: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">
                      <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">SHARED VOTING POWER</div>
                      <div style="line-height: 1.25;"><font style="line-height: 1.25;">&#160;</font></div>
                      <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">
                        <div style="line-height: 1.25;">747,445 (1)</div>
                      </div>
                    </td>
                  </tr>
                  <tr valign="top">
                    <td width="7%" style="border-left: 2px solid black; border-bottom: 2px solid black; text-align: left; vertical-align: top;"><font size="2" style="font-family: times new roman,times,serif;">9</font></td>
                    <td width="7%" style="BORDER-RIGHT: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">
                      <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">SOLE DISPOSITIVE POWER</div>
                      <div style="line-height: 1.25;"><font style="line-height: 1.25;">&#160;</font></div>
                      <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">0</div>
                    </td>
                  </tr>
                  <tr valign="top">
                    <td width="7%" style="border-left: 2px solid black; border-bottom: 2px solid black; text-align: left; vertical-align: top;"><font size="2" style="font-family: times new roman,times,serif;">10</font></td>
                    <td width="7%" style="BORDER-RIGHT: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left">
                      <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">SHARED DISPOSITIVE POWER</div>
                      <div style="line-height: 1.25;"><font style="line-height: 1.25;">&#160;</font></div>
                      <div style="line-height: 1.25; font-family: 'Times New Roman', Times, serif;">
                        <div style="line-height: 1.25;">747,445 (1)</div>
                      </div>
                    </td>
                  </tr>
                  <tr valign="top">
                    <td width="7%" style="border-right: 1px none black; border-left: 2px solid black; border-bottom: 2px solid black; text-align: left; vertical-align: top;"><font size="2" style="font-family: times new roman,times,serif;">11</font></td>
                    <td width="7%" colspan="3" style="BORDER-RIGHT: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-BOTTOM: black 2px solid">
                      <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON</div>
                      <div style="line-height: 1.25;"><font style="line-height: 1.25;">&#160;</font></div>
                      <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">
                        <div style="line-height: 1.25;">747,445 (1)</div>
                      </div>
                    </td>
                  </tr>
                  <tr valign="top">
                    <td width="7%" style="border-right: 1px none black; border-left: 2px solid black; border-bottom: 2px solid black; text-align: left; vertical-align: top;"><font size="2" style="font-family: times new roman,times,serif;">12</font></td>
                    <td width="7%" colspan="3" style="BORDER-RIGHT: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-BOTTOM: black 2px solid">
                      <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)</div>
                      <div style="text-align: left; line-height: 1.25;">&#160;<br>
                      </div>
                      <div style="text-align: left; line-height: 1.25;">&#9744; </div>
                    </td>
                  </tr>
                  <tr valign="top">
                    <td width="7%" style="border-right: 1px none black; border-left: 2px solid black; border-bottom: 2px solid black; text-align: left; vertical-align: top;"><font size="2" style="font-family: times new roman,times,serif;">13</font></td>
                    <td width="7%" colspan="3" style="BORDER-RIGHT: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-BOTTOM: black 2px solid">
                      <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)</div>
                      <div style="line-height: 1.25;"><font style="line-height: 1.25;">&#160;</font></div>
                      <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">
                        <div style="line-height: 1.25;">6.4% (2)</div>
                      </div>
                    </td>
                  </tr>
                  <tr valign="top">
                    <td width="7%" style="border-right: 1px none black; border-left: 2px solid black; border-bottom: 2px solid black; text-align: left; vertical-align: top;"><font size="2" style="font-family: times new roman,times,serif;">14</font></td>
                    <td width="7%" colspan="3" style="BORDER-RIGHT: black 2px solid; BORDER-LEFT: black 2px solid; BORDER-BOTTOM: black 2px solid">
                      <div style="text-align: left; line-height: 1.25; font-family: 'Times New Roman', Times, serif;">TYPE OF REPORTING PERSON (See Instructions)</div>
                      <div style="line-height: 1.25;"><font style="line-height: 1.25;">&#160;</font></div>
                      <div style="line-height: 1.25;">IN<font style="line-height: 1.25;"> </font></div>
                    </td>
                  </tr>

              </table>
            </div>
          </div>
          <div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>
        </div>
      </div>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="zccbe07b8908641f7b07f8a5cec987a62">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">(1)</td>
          <td style="width: auto; vertical-align: top;">
            <div>
              <div style="line-height: 1.25;">Consists of (i) 324,775 ADSs owned directly by Dr. Adi Mor (the Reporting Person&#8217;s spouse), (ii) 257,247 ADSs owned by the Reporting Person, (iii) 131,698 ADSs issuable upon the exercise of options held by Dr.
                Adi Mor, and (iv) 33,725 ADSs issuable to the Reporting Person upon the exercise of options held by him.</div>
            </div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable" id="z3bc67dac8adb4f8b9754dd55f01e0691">

        <tr>
          <td style="width: 18pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right;">(2)</td>
          <td style="width: auto; vertical-align: top;">
            <div>
              <div style="line-height: 1.25;">The percentage presented is based on 11,525,605 ADSs outstanding as of November 8, 2022, as reported by the Issuer in its Form 10-Q as filed with the Securities and Exchange Commission on November 10, 2022.</div>
            </div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">
      <div style="line-height: 1.25;">
        <div style="text-align: center; line-height: 1.25; font-weight: bold;">AMENDMENT NO. 1 TO SCHEDULE 13D</div>
      </div>
      <div style="line-height: 1.25;">
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="text-indent: 35.45pt; line-height: 1.25;">This Amendment No. 1 to Schedule 13D (this &#8220;Amendment&#8221;) is being filed by Dr. Adi Mor and her spouse, Prof. Kobi George (collectively, the &#8220;Reporting Individuals&#8221;, and each, a &#8220;Reporting
          Individual&#8221;) relating to the American Depositary Shares, which represent twenty (20) ordinary shares, no par value, of Chemomab Therapeutics Ltd. (the &#8220;ADSs&#8221; and the &#8220;Issuer,&#8221; respectively).</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-indent: 35.45pt; line-height: 1.25;">The Schedule 13D filed with the Securities and Exchange Commission (the &#8220;SEC&#8221;) on January 20, 2022 (the &#8220;Schedule&#8221;) is hereby amended and supplemented by the Reporting Individuals as set forth
          below in this Amendment. This Amendment is filed by the Reporting Individuals in accordance&#160;with Rule 13d-2 of&#160;the&#160;Securities Exchange Act of 1934, as amended, and refers only to information that has materially changed since the filing of the
          Schedule. The items identified below, or the particular paragraphs of such items which are identified below, are amended as set forth below. Unless otherwise indicated, all capitalized terms used and not defined herein have the respective
          meanings assigned to them in the Schedule.</div>
      </div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="margin-left: 36pt; line-height: 1.25;">Items 4, 5, and 7 of the Schedule are hereby amended and restated to state as follows:</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25; font-weight: bold;">Item 4. Purpose of Transaction.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-indent: 36pt; line-height: 1.25;">Dr. Adi Mor serves as a member of the Board of Directors and Chief Scientific Officer of the Issuer, and, in such capacities, may have influence over the corporate activities of the Issuer, including
        activities which may relate to items described in subparagraphs (a) through (j) of Item 4 of Schedule 13D.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-indent: 36pt; line-height: 1.25;">As discussed in the Issuer&#8217;s Quarterly Report on Form 10-Q, as filed with the SEC on November 10, 2022, in connection with the merger consummated between the Issuer and Chemomab Ltd., certain
        shareholders of Chemomab Ltd. were entitled to defer an immediate Israeli tax liability resulting from the exchange of shares that otherwise would have been deemed a sale. The deferral is set to lapse on March 16, 2023. Each of the Reporting
        Individuals&#8212; Dr. Adi Mor, co-founder of Chemomab Ltd. and both the Issuer&#8217;s Chief Scientific Officer and one of its Class III directors, and Prof. Kobi George, co-founder of Chemomab Ltd.&#8212; will be required to pay a substantial tax liability to the
        Israeli Tax Authority upon the expiration date of the deferral period. In order to cover this tax liability, the Reporting Individuals will be required to sell part of their holdings in the Issuer.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-indent: 36pt; line-height: 1.25;">In light of the foregoing, the Issuer elected to enter into a share purchase agreement (the &#8220;Repurchase Arrangement&#8221;) with the Reporting Individuals whereby the Issuer agreed, subject to the
        requisite court approval required under Section 303(a) of the Israeli Companies Law, 5759-1999 (the &#8220;Companies Law&#8221;), which the Issuer received on November 14, 2022, to repurchase up to 582,023 ADSs of the Issuer owned by the Reporting Individuals,
        for consideration not to exceed an aggregate amount of $2,500,000, depending on the market price of the ADSs at the time of any repurchase.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-indent: 36pt; line-height: 1.25;">Accordingly, on November 16, 2022, the Issuer repurchased the entire amount of 582,023 ADSs from the Reporting Individuals at a weighted average price of $2.0848 and for total consideration of
        approximately $1,213,400.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-indent: 36pt; line-height: 1.25;">The Reporting Individuals intend to continue to review their investment in the Issuer and may, based on such review as well as other factors (including, among other things, their evaluation of the
        Issuer&#8217;s business, prospects and financial condition, amounts and prices of available ADSs, the market for the Issuer&#8217;s securities, other opportunities available to the Reporting Individuals and general market and economic conditions), acquire
        additional ADSs of the Issuer or sell ADSs of the Issuer, on the open market or in privately negotiated transactions. The Reporting Individuals reserve the right at any time to change their present intention with respect to any or all of the
        matters referred to in this Item 4, or to dispose of any or all of the ADSs of the Issuer (subject to any applicable requirement to update the Statement as a result of any such changed intent or disposition of ADSs of the Issuer under the rules of
        the SEC).</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-indent: 36pt; line-height: 1.25;">Except as set forth herein, as of the filing of this Amendment, the Reporting Individuals do not have any definitive plans or proposals which relate to or would result in any of the following: (a)
        the acquisition by either of the Reporting Individuals of additional ADSs, or the disposition of ADSs that such person holds; (b) an extraordinary corporate transaction, such as a merger, reorganization or liquidation, involving the Issuer or any
        of its subsidiaries; (c) a sale or transfer of a material amount of assets of the Issuer or any of its subsidiaries; (d) a material change in the present capitalization or dividend policy of the Issuer; (e) any other material change in the Issuer&#8217;s
        business or corporate structure; (f) changes in the Issuer&#8217;s articles of association or other actions which may impede the acquisition of control of the Issuer by any other person; (g) causing the Issuer&#8217;s ADSs to be delisted from a national
        securities exchange (such as the Nasdaq Stock Market LLC, on which the ADSs are currently listed) or to cease to be authorized to be quoted in an inter-dealer quotation system of a registered national securities association; (h) causing the ADSs to
        become eligible for termination of registration pursuant to Section 12(g)(4) of the Securities Exchange Act of 1934, as amended; or (j) any action similar to any of those enumerated above.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25; font-weight: bold;">Item 5. Interest in Securities of the Issuer.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-indent: 36pt; line-height: 1.25;">All calculations of beneficial ownership percentage in this Amendment No. 1 are made on the basis of 11,525,605 ADSs issued and outstanding as of November 8, 2022, as reported by the Issuer in its
        Quarterly Report on Form 10-Q as filed with the SEC on November 10, 2022.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-indent: 36pt; line-height: 1.25;">(a) Because of their spousal relationship, each of the Reporting Individuals may be deemed to beneficially own 747,445 ADSs of the Issuer, representing approximately 6.5% of the issued and
        outstanding share capital of the Issuer, constituting the aggregate number and percentage of ADSs beneficially owned by the Reporting Individuals as a whole. Each of the Reporting Individuals possesses shared voting and dispositive power with
        respect to all of those 747,445 ADSs.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-indent: 36pt; line-height: 1.25;">(b) The Reporting Individuals possess shared power to vote and direct the vote, and shared power to dispose or to direct the disposition of 747,445 ADSs of the Issuer, as described in paragraph (a)
        of this Item 5 above. Those 747,445 ADSs consist of (i) 324,775 ADSs owned directly by Dr. Adi Mor, (ii) 257,247 ADSs owned by Prof. Kobi George, (Dr. Adi Mor&#8217;s spouse), (iii) 131,698 ADSs issuable upon the exercise of options held by Dr. Adi Mor,
        and (iv) 33,725 ADSs issuable to Prof. Kobi George upon the exercise of options held by him.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-indent: 36pt; line-height: 1.25;">(c) On November 16, 2022, the Reporting Individuals collectively sold 582,023 ADSs at a weighted average price of $2.0848, as further described in Item 4 above. Except for the disposition pursuant to
        the Repurchase Arrangement, neither of the Reporting Individuals has effected any transactions in securities of the Issuer in the past 60 days.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-indent: 35.45pt; line-height: 1.25;">(d) Not applicable.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="text-indent: 36pt; line-height: 1.25;">(e) Not applicable.</div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25; font-weight: bold;">Item 7. Material to be Filed as Exhibits.</div>
      <div style="line-height: 1.25;">&#160;</div>
      <table cellspacing="0" cellpadding="0" border="0" align="center" id="z83eb60e1092143c0b4b193b42e331960" style="width: 95%; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left;">

          <tr>
            <td style="width: 8%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><a href="exhibit_1.htm">Exhibit 1.</a></div>
            </td>
            <td style="width: 92%; vertical-align: top;">
              <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><a href="exhibit_1.htm">Joint Filing Agreement pursuant to Rule 13d-1(k)(1)</a></div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: center; line-height: 1.25; font-weight: bold;">SIGNATURE</div>
      <div style="line-height: 1.25;">&#160;</div>
      <div style="text-indent: 36pt; line-height: 1.25;">After reasonable inquiry and to the best of the knowledge and belief of the undersigned, we certify that the information set forth in this statement is true, complete and correct.</div>
      <div style="line-height: 1.25;">&#160;</div>
      <div style="line-height: 1.25;">Dated: <u>November 17, 2022</u></div>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <table cellspacing="0" cellpadding="0" border="0" id="z0004b40bb7134993a8f0ba927e5890d4" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 50%; vertical-align: middle;">
              <div style="line-height: 1.25;">&#160;</div>
            </td>
            <td style="width: 50%; vertical-align: middle;">
              <div style="line-height: 1.25;"><u>/s/ Adi Mor</u></div>
              <div style="line-height: 1.25; font-weight: bold;">ADI MOR</div>
              <div style="line-height: 1.25;"><font style="line-height: 1.25;">&#160;</font></div>
              <div style="line-height: 1.25;"><u>/s/ Kobi George</u></div>
              <div style="line-height: 1.25; font-weight: bold;">KOBI GEORGE</div>
            </td>
          </tr>

      </table>
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
    </div>
    <br>
    <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"><br>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99
<SEQUENCE>2
<FILENAME>exhibit_1.htm
<DESCRIPTION>EXHIBIT 1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: ZKG
         Document created using Broadridge PROfile 22.10.1.5080
         Copyright 1995 - 2022 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <div style="line-height: 1.25;">
      <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25">
        <div style="line-height: 1.25;">
          <div style="text-align: right; line-height: 1.25; font-weight: bold;"><u>Exhibit 1</u></div>
        </div>
        <div style="line-height: 1.25;">
          <div style="line-height: 1.25;"><br style="line-height: 1.25;">
          </div>
        </div>
        <div style="line-height: 1.25;">
          <div style="text-align: center; line-height: 1.25;">JOINT FILING AGREEMENT</div>
        </div>
        <div style="line-height: 1.25;">
          <div style="line-height: 1.25;"><br style="line-height: 1.25;">
          </div>
        </div>
        <div style="line-height: 1.25;">
          <div style="text-indent: 35.45pt; line-height: 1.25;">The undersigned parties hereby agree that this Amendment No. 1 to Schedule 13D filed herewith relating to the
            American Depositary Shares, each representing twenty (20) ordinary shares, no par value per share of Chemomab Therapeutics Ltd., is being filed jointly with the Securities and Exchange Commission pursuant to Rule 13d-1(k) on behalf of each such
            person.</div>
        </div>
        <div style="line-height: 1.25;">
          <div style="line-height: 1.25;"><br style="line-height: 1.25;">
          </div>
          <div style="line-height: 1.25;">Date: <u>November 17, 2022</u></div>
          <div style="line-height: 1.25;"><br style="line-height: 1.25;">
          </div>
        </div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 50%; vertical-align: middle;">
                <div style="line-height: 1.25;">&#160;</div>
              </td>
              <td style="width: 50%; vertical-align: middle;">
                <div style="line-height: 1.25;"><u>/s/ Adi Mor</u></div>
                <div style="line-height: 1.25; font-weight: bold;">ADI MOR</div>
                <div style="line-height: 1.25;"><font style="line-height: 1.25;">&#160;</font></div>
                <div style="line-height: 1.25;"><u>/s/ Kobi George</u></div>
                <div style="line-height: 1.25; font-weight: bold;">KOBI GEORGE</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
      </div>
      <div style="line-height: 1.25;">
        <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
